Zobrazeno 1 - 10
of 301
pro vyhledávání: '"Groen HJ"'
Autor:
Hobbs, BD, de Jong, K, Lamontagne, M, Bossé, Y, Shrine, N, Artigas, MS, Wain, LV, Hall, IP, Jackson, VE, Wyss, AB, London, SJ, North, KE, Franceschini, N, Strachan, DP, Beaty, TH, Hokanson, JE, Crapo, JD, Castaldi, PJ, Chase, RP, Bartz, TM, Heckbert, SR, Psaty, BM, Gharib, SA, Zanen, P, Lammers, JW, Oudkerk, M, Groen, HJ, Locantore, N, Tal-Singer, R, Rennard, SI, Vestbo, J, Timens, W, Paré, PD, Latourelle, JC, Dupuis, J, O'Connor, GT, Wilk, JB, Kim, WJ, Lee, MK, Oh, Y-M, Vonk, JM, de Koning, HJ, Leng, S, Belinsky, SA, Tesfaigzi, Y, Manichaikul, A, Wang, X-Q, Rich, SS, Barr, RG, Sparrow, D, Litonjua, AA, Bakke, P, Gulsvik, A, Lahousse, L, Brusselle, GG, Stricker, BH, Uitterlinden, AG, Ampleford, EJ, Bleecker, ER, Woodruff, PG, Meyers, DA, Qiao, D, Lomas, DA, Yim, J-J, Kim, DK, Hawrylkiewicz, I, Sliwinski, P, Hardin, M, Fingerlin, TE, Schwartz, DA, Postma, DS, MacNee, W, Tobin, MD, Silverman, EK, Boezen, HM, Cho, MH, COPDGene Investigators, ECLIPSE Investigators, LifeLines Investigators, SPIROMICS Research Group, International COPD Genetics Network Investigators, UK BiLEVE Investigators, International COPD Genetics Consortium
Publikováno v:
Nature Genetics
Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality worldwide. We performed a genetic association study in 15,256 cases and 47,936 controls, with replication of select top results (P < 5 × 10(-6)) in 9,498 cases and 9,748 co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::834c3a21a0c01477de684e2e7b49ebc3
https://openaccess.sgul.ac.uk/id/eprint/108399/7/NG-LE43518R_main_paper.pdf
https://openaccess.sgul.ac.uk/id/eprint/108399/7/NG-LE43518R_main_paper.pdf
Autor:
Dubois PC, Trynka G, Francke L, Hunt KA, Rpmanos J, Curtotti A, Zhernakova A, Heap GA, Adàny R, Aromaa A, Bardella MT, Van Den Berg LH, Bockett NA, De La Concha EG, DEma B, Fehrmann RS, Fernandez Aquero M, Fiatal S, Grandone E, Green PM, Groen HJ, Gwilliam R, Houwn RH, Hunt SE, Kaukinen K, Kelleher D, Korponay Szabo I, Kurppa K, Mac Mathuna P, Maki M, Mazzilli MC, McCann OT, Mearin ML, Mein CA, Mirza MM, Mistry V, Mora B, Morley KI, Mulder CJ, Murray JA, Nunez C, Oosterom E, Ophoff RA, Polanco I, Peltonen L, Platteel M, Rybak A, Salomaa V, Schweizer JJ, Sperandeo MP, Tack GJ, Turner G, Veldink JH, Verbeek WH, Weersma RK, Wolters WM, Urcelay E, Cukrowska B, Neuhausen SL, McManus R, Barisani D, Deloukas P, Barrett JC, Saavalainen P, Wijmenga C, Van Heel DA, GRECO, LUIGI
We performed a second-generation genome-wide association study of 4,533 individuals with celiac disease (cases) and 10,750 control subjects. We genotyped 113 selected SNPs with P(GWAS) < 10(-4) and 18 SNPs from 14 known loci in a further 4,918 cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::a9f83733ed613dd5b9f22f2c58da1f02
http://hdl.handle.net/11588/365958
http://hdl.handle.net/11588/365958
Autor:
Wolf, J, Garon, E B, Groen, HJ M, Tan, DS W, Robeva, A, Le Mouhaer, S, Carbini, M, Chassot-Agostinho, A, Heist, R S
Publikováno v:
Pneumologie; 2022 Supplement, Vol. 76, pS39-S40, 2p
Autor:
Kehrer, DFS, Bos, AM, Verweij, J, Groen, HJ, Loos, WJ, Sparreboom, A, Hamilton, M, Cameron, T, de Vries, EGE
Publikováno v:
Journal of Clinical Oncology, 20(5), 1222-1231. AMER SOC CLINICAL ONCOLOGY
Purpose: To determine the maximum-tolerated and recommended dose, toxicity profile, and pharmacokinetics of the liposomal topoisomerase 1 inhibitor lurtotecan (NX 211) administered as a 30-minute intravenous infusion once every 3 weeks in cancer pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::9b2a08705841b83339457f6a227b10ea
https://research.rug.nl/en/publications/1bd0243f-1ad8-42e6-b312-dca4010dff9c
https://research.rug.nl/en/publications/1bd0243f-1ad8-42e6-b312-dca4010dff9c
Publikováno v:
OncoTargets and Therapy, Vol Volume 12, Pp 1413-1421 (2019)
Marscha S Holleman,1,2 Harm van Tinteren,3 Harry JM Groen,4 Maiwenn J Al,1,2 Carin A Uyl-de Groot1,2 1Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands; 2Institute for Medical Technology Assessme
Externí odkaz:
https://doaj.org/article/6d4970ec64d64d7181448a08021fa647
Publikováno v:
Journal of Thoracic Oncology; 2013 Feb, Vol. 8 Issue 2, p214-221, 8p
Autor:
Kuiper JL, Lind JS, Groen HJ, Roder J, Grigorieva J, Roder H, Dingemans AM, Smit EF, Kuiper, J L, Lind, J S W, Groen, H J M, Roder, J, Grigorieva, J, Roder, H, Dingemans, A M C, Smit, E F
Publikováno v:
British Journal of Cancer; 11/20/2012, Vol. 107 Issue 11, p1820-1825, 6p
Publikováno v:
Clinical Lung Cancer; 2012 Nov, Vol. 13 Issue 6, p475-481, 7p
Autor:
Blumenschein GR Jr, Ciuleanu T, Robert F, Groen HJ, Usari T, Ruiz-Garcia A, Tye L, Chao RC, Juhasz E, Blumenschein, George R Jr, Ciuleanu, Tudor, Robert, Francisco, Groen, Harry J M, Usari, Tiziana, Ruiz-Garcia, Ana, Tye, Lesley, Chao, Richard C, Juhasz, Erzsebet
Publikováno v:
Journal of Thoracic Oncology; 2012 Sep, Vol. 7 Issue 9, p1406-1416, 11p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.